Key result
Hyperleptinemia promotes atherosclerosis by acting directly on vascular cells via the leptin receptor.
Answers are grounded in this paper and cite their sources.
Increasing adipose tissue mass in obesity directly correlates with elevated circulating leptin levels. Leptin is an adipokine known to play a role in numerous biological processes including regulation of energy homeostasis, inflammation, vascular function and angiogenesis. While physiological concentrations of leptin may exhibit multiple beneficial effects, chronically elevated pathophysiological levels or hyperleptinemia, characteristic of obesity and diabetes, is a major risk factor for development of atherosclerosis. Hyperleptinemia results in a state of selective leptin resistance such that while beneficial metabolic effects of leptin are dampened, deleterious vascular effects of leptin are conserved attributing to vascular dysfunction. Leptin exerts potent proatherogenic effects on multiple vascular cell types including macrophages, endothelial cells and smooth muscle cells; these effects are mediated via an interaction of leptin with the long form of leptin receptor, abundantly expressed in atherosclerotic plaques. This review provides a summary of recent in vivo and in vitro studies that highlight a role of leptin in the pathogenesis of atherosclerotic complications associated with obesity and diabetes.
No takes yet. Share an insight, caveat, or question.
Raman et al. (2021) conducted a review in Atherosclerosis associated with obesity and diabetes. Leptin (hyperleptinemia) was evaluated on Pathogenesis of atherosclerosis via effects on macrophages, endothelial cells, and smooth muscle cells. Hyperleptinemia in obesity and diabetes exerts proatherogenic effects on macrophages, endothelial cells, and smooth muscle cells via the long form of the leptin receptor.
Synapse has enriched 10 related papers. Consider them for comparative context: